Hamideh Afzali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hamideh Afzali has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Aisan Peyrovan
Skin and Stem Cell Research Center Tehran University of Medical Sciences Tehran Iran
2 shared publicationsEbrahim Khodaverdi Darian
Department of Medical Biotechnology School of Medicine Semnan University of Medical Sciences Semnan Iran
2 shared publications- Maryam Nouri
Skin and Stem Cell Research Center Tehran University of Medical Sciences Tehran Iran
2 shared publications - Mohammad Ali Nilforoushzadeh
Skin and Stem Cell Research Center Tehran University of Medical Sciences Tehran Iran
2 shared publications - Sona Zare
Skin and Stem Cell Research Center Tehran University of Medical Sciences Tehran Iran
2 shared publications Zahra Razzaghi
Laser Application in Medical Sciences Research Center Shahid Beheshti University of Medical Sciences Tehran Iran
2 shared publications
Latest Publications
- Open Access
- 4 November 2025
- Published by Wiley in Aging Cell
- Vol. 24 (12) , e70217
Single Cell Sequencing Identifies Distinct Cellular Alterations in Impaired Aged and Diabetic Wounds
Impaired wound healing in aged and diabetic wounds involves complex cellular dysregulation that hinders tissue repair. Using single‐cell RNA sequencing (scRNA‐seq) and validation techniques, we investigated impaired wound healing to identify whether there were significant changes linked to each condition. Comparative mucosal wound analysis revealed distinct differences between diabetic and normoglycemic (NG)‐aged mice, which had an impact on connective tissue formation and epithelial closure. Wounds in NG‐aged mice exhibited prolonged granulation tissue and upregulation of genes linked to chemotaxis, cell migration, neutrophil degranulation, and antimicrobial defense pathways compared to the diabetic wounds. In comparison to healing in young animals, wounds in NG‐aged mice had a shift in fibroblast subtypes with fewer matrix‐producing myofibroblasts and increased inflammatory fibroblasts. Furthermore, wounds in NG‐aged mice versus wounds in diabetic mice had an upregulation of lytic enzymes, with striking differences in cathepsin‐expressing fibroblasts. Since diabetic wounds healed more slowly than wounds in NG‐aged mice, the results suggest that the upregulation of lytic enzymes that characterized diabetic wounds is particularly damaging to healing. In addition to the transcriptional differences, pseudotime analysis revealed that fibroblasts in wounds from diabetic mice progressed towards a protease‐enriched state, while those in aged mice shifted towards an inflammatory phenotype. This is the first study to directly compare aged and diabetic healing at the single‐cell level and provides distinct molecular mechanisms that may allow more precise therapeutic targets to improve healing in aged and diabetic wounds.
- 4 November 2025
- Published by Wiley in Aging Cell
- Vol. 24 (12) , e70217
Open AccessSingle Cell Sequencing Identifies Distinct Cellular Alterations in Impaired Aged and Diabetic Wounds
Impaired wound healing in aged and diabetic wounds involves complex cellular dysregulation that hinders tissue repair. Using single‐cell RNA sequencing (scRNA‐seq) and validation techniques, we investigated impaired wound healing to identify whether there were significant changes linked to each condition. Comparative mucosal wound analysis revealed distinct differences between diabetic and normoglycemic (NG)‐aged mice, which had an impact on connective tissue formation and epithelial closure. Wounds in NG‐aged mice exhibited prolonged granulation tissue and upregulation of genes linked to chemotaxis, cell migration, neutrophil degranulation, and antimicrobial defense pathways compared to the diabetic wounds. In comparison to healing in young animals, wounds in NG‐aged mice had a shift in fibroblast subtypes with fewer matrix‐producing myofibroblasts and increased inflammatory fibroblasts. Furthermore, wounds in NG‐aged mice versus wounds in diabetic mice had an upregulation of lytic enzymes, with striking differences in cathepsin‐expressing fibroblasts. Since diabetic wounds healed more slowly than wounds in NG‐aged mice, the results suggest that the upregulation of lytic enzymes that characterized diabetic wounds is particularly damaging to healing. In addition to the transcriptional differences, pseudotime analysis revealed that fibroblasts in wounds from diabetic mice progressed towards a protease‐enriched state, while those in aged mice shifted towards an inflammatory phenotype. This is the first study to directly compare aged and diabetic healing at the single‐cell level and provides distinct molecular mechanisms that may allow more precise therapeutic targets to improve healing in aged and diabetic wounds.
- 13 September 2022
- Published by Wiley in Cell Biochemistry and Function
- Vol. 40 (7) , 750-759
Chronic nitrate administration increases the expression the genes involved in the browning of white adipose tissue in female rats
Nitrate, a nitric oxide (NO) donor, has antiobesity effect in female rats. This study hypothesized that the antiobesity effect of nitrate in female rats is due to the browning of white adipose tissue (WAT). Female Wistar rats (aged 8 months) were divided into two groups (n = 10/group): the control group received tap water and the nitrate group received water containing 100 mg/L of sodium nitrate for 9 months. At months 0, 3, 6, and 9, obesity indices were measured. At month 9, gonadal adipose tissue was used to measure messenger RNA (mRNA) and protein levels of peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), PPAR‐γ coactivator 1‐α (PGC1‐α), uncoupling protein 1 (UCP1), and adipocyte density and area. After the 9‐month intervention, nitrate‐treated rats had lower body weight, body mass index, thoracic circumference, and abdominal circumference by 6.4% (p = .012), 9.1% (p = .029), 6.0% (p = .056), and 5.7% (p = .098), respectively. In addition, nitrate‐treated rats had higher PPAR‐γ (mRNA: 1.78‐fold, p = .016 and protein: 19%, p = .076), PGC1‐α (mRNA: 1.69‐fold, p = .012 and protein: 68%, p = .001), and UCP1 (mRNA: 2.50‐fold, p = .001 and protein: 81%, p = .001) in gonadal adipose tissue. Nitrate also reduced adipocyte area by 35% (p = .054) and increased adipocyte density by 31% (p = .086). In conclusion, antiobesity effect of nitrate in female rats is associated with increased browning of gonadal adipose tissue as indicated by higher expression of PPAR‐γ, PGC1‐α, and UCP1 and reduced adipocyte area and increased adipocyte density.
- 13 September 2022
- Published by Wiley in Cell Biochemistry and Function
- Vol. 40 (7) , 750-759
Chronic nitrate administration increases the expression the genes involved in the browning of white adipose tissue in female rats
Nitrate, a nitric oxide (NO) donor, has antiobesity effect in female rats. This study hypothesized that the antiobesity effect of nitrate in female rats is due to the browning of white adipose tissue (WAT). Female Wistar rats (aged 8 months) were divided into two groups (n = 10/group): the control group received tap water and the nitrate group received water containing 100 mg/L of sodium nitrate for 9 months. At months 0, 3, 6, and 9, obesity indices were measured. At month 9, gonadal adipose tissue was used to measure messenger RNA (mRNA) and protein levels of peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), PPAR‐γ coactivator 1‐α (PGC1‐α), uncoupling protein 1 (UCP1), and adipocyte density and area. After the 9‐month intervention, nitrate‐treated rats had lower body weight, body mass index, thoracic circumference, and abdominal circumference by 6.4% (p = .012), 9.1% (p = .029), 6.0% (p = .056), and 5.7% (p = .098), respectively. In addition, nitrate‐treated rats had higher PPAR‐γ (mRNA: 1.78‐fold, p = .016 and protein: 19%, p = .076), PGC1‐α (mRNA: 1.69‐fold, p = .012 and protein: 68%, p = .001), and UCP1 (mRNA: 2.50‐fold, p = .001 and protein: 81%, p = .001) in gonadal adipose tissue. Nitrate also reduced adipocyte area by 35% (p = .054) and increased adipocyte density by 31% (p = .086). In conclusion, antiobesity effect of nitrate in female rats is associated with increased browning of gonadal adipose tissue as indicated by higher expression of PPAR‐γ, PGC1‐α, and UCP1 and reduced adipocyte area and increased adipocyte density.
- 10 May 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (10) , 5156-5167
Topical spray of Wharton's jelly mesenchymal stem cells derived from umbilical cord accelerates diabetic wound healing
Background and Aim: Cell‐based therapy utilizing mesenchymal stem cells (MSCs) is currently being investigated as a therapeutic agent for chronic wounds. There is no evidence regarding effectiveness of the spray and local transfer of this cellular product in diabetic wound healing. Accordingly, the present study, using clinical, pathological and biometric parameters, investigated the effectiveness of the spray of these cells in the healing of diabetic wounds in rats.Methods: Three days after the induction of diabetes (50 mg/kg single dose of streptozotocin) a circular excision was created on the back of rats. Diabetic rats were divided into two groups (n = 21): Control and WJ‐MSCs group. Sampling of the studied groups was performed on Days 7, 14, and 21 after wounding. Histological, ultrasound imaging of dermis and epidermis in the wound area for thickness and density measurement and skin elasticity were evaluated.Results: Our results on Days 7, 14, and 21 after wounding showed that the wound closure, thickness, and density of new epidermis and dermis, as well as skin elasticity in healed wound were significantly higher in WJ‐MSCs group compared with the Control group.Conclusion: Application of WJ‐MSCs suspension spray on the wound area can accelerate healing in diabetic wounds. Our findings may potentially provide a helpful therapeutic strategy for patients with a diabetic wound.
- 10 May 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (10) , 5156-5167
Topical spray of Wharton's jelly mesenchymal stem cells derived from umbilical cord accelerates diabetic wound healing
Background and Aim: Cell‐based therapy utilizing mesenchymal stem cells (MSCs) is currently being investigated as a therapeutic agent for chronic wounds. There is no evidence regarding effectiveness of the spray and local transfer of this cellular product in diabetic wound healing. Accordingly, the present study, using clinical, pathological and biometric parameters, investigated the effectiveness of the spray of these cells in the healing of diabetic wounds in rats.Methods: Three days after the induction of diabetes (50 mg/kg single dose of streptozotocin) a circular excision was created on the back of rats. Diabetic rats were divided into two groups (n = 21): Control and WJ‐MSCs group. Sampling of the studied groups was performed on Days 7, 14, and 21 after wounding. Histological, ultrasound imaging of dermis and epidermis in the wound area for thickness and density measurement and skin elasticity were evaluated.Results: Our results on Days 7, 14, and 21 after wounding showed that the wound closure, thickness, and density of new epidermis and dermis, as well as skin elasticity in healed wound were significantly higher in WJ‐MSCs group compared with the Control group.Conclusion: Application of WJ‐MSCs suspension spray on the wound area can accelerate healing in diabetic wounds. Our findings may potentially provide a helpful therapeutic strategy for patients with a diabetic wound.
- 2 May 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (10) , 4669-4676
Combination of epidermal keratinocyte–melanocyte cells suspension and microneedling: Safe surgical approach in vitiligo
Introduction: Vitiligo is a skin disease that is associated with impaired skin immune systems and pigment degradation in skin melanocyte cells. Despite the significant impact of the disease on the quality of life of patients, treatment of the disease using an effective method such as the transplantation of uncultivated melanocytes was considered by researchers around the world. The goal of this research was to use microneedling to transplant epidermal keratinocyte–melanocyte cells suspension for the treatment of vitiligo patients.Methods: In this study, 15 male and female vitiligo in face region patients aged 18–45 years were studied. In this study, melanocyte–keratinocyte cells suspension was sprayed. Patients underwent microneedling treatment after spraying the cells. Before and after transplantation, patients were biometrically examined, and the quantity of pigmentation and changes in the transplanted region were documented. Statistical software was used to examine the results.Results: The color difference between the lesion area and normal skin in one, two, and six months after treatment with cell suspension was significantly reduced compared with before treatment (by 48.95%). Moreover, the amount of melanin was significantly increased 6 months after treatment compared with before treatment (129.8 ± 4.16 vs. 195.2 ± 3.54, p = 0.000). A significant decrease in skin brightness in the skin of the lesion area was observed compared with normal skin, 6 months after treatment compared with before treatment (43.7 ± 1.44 vs. 27.9 ± 1.24, p = 0.000).Conclusion: Epidermal keratinocyte–melanocyte cells suspension in combination with microneedling could be considered as an effective treatment of vitiligo.
- 2 May 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (10) , 4669-4676
Combination of epidermal keratinocyte–melanocyte cells suspension and microneedling: Safe surgical approach in vitiligo
Introduction: Vitiligo is a skin disease that is associated with impaired skin immune systems and pigment degradation in skin melanocyte cells. Despite the significant impact of the disease on the quality of life of patients, treatment of the disease using an effective method such as the transplantation of uncultivated melanocytes was considered by researchers around the world. The goal of this research was to use microneedling to transplant epidermal keratinocyte–melanocyte cells suspension for the treatment of vitiligo patients.Methods: In this study, 15 male and female vitiligo in face region patients aged 18–45 years were studied. In this study, melanocyte–keratinocyte cells suspension was sprayed. Patients underwent microneedling treatment after spraying the cells. Before and after transplantation, patients were biometrically examined, and the quantity of pigmentation and changes in the transplanted region were documented. Statistical software was used to examine the results.Results: The color difference between the lesion area and normal skin in one, two, and six months after treatment with cell suspension was significantly reduced compared with before treatment (by 48.95%). Moreover, the amount of melanin was significantly increased 6 months after treatment compared with before treatment (129.8 ± 4.16 vs. 195.2 ± 3.54, p = 0.000). A significant decrease in skin brightness in the skin of the lesion area was observed compared with normal skin, 6 months after treatment compared with before treatment (43.7 ± 1.44 vs. 27.9 ± 1.24, p = 0.000).Conclusion: Epidermal keratinocyte–melanocyte cells suspension in combination with microneedling could be considered as an effective treatment of vitiligo.